Journal ArticleDOI
Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing
Ramin Mojtabai,Mark Olfson +1 more
Reads0
Chats0
TLDR
To the extent that antidepressants are being prescribed for uses not supported by clinical evidence, there may be a need to improve providers' prescribing practices, revamp drug formularies, or vigorously pursue implementation of broad reforms of the health care system that will increase communication between primary care providers and mental health specialists.Abstract:
Over the past two decades, the use of antidepressant medications has grown to the point that they are now the third most commonly prescribed class of medications in the United States. Much of this growth has been driven by a substantial increase in antidepressant prescriptions by nonpsychiatrist providers without an accompanying psychiatric diagnosis. Our analysis found that between 1996 and 2007, the proportion of visits at which antidepressants were prescribed but no psychiatric diagnoses were noted increased from 59.5 percent to 72.7 percent. These results do not clearly indicate a rise in inappropriate antidepressant use, but they highlight the need to gain a deeper understanding of the factors driving this national trend and to develop effective policy responses. To the extent that antidepressants are being prescribed for uses not supported by clinical evidence, there may be a need to improve providers’ prescribing practices, revamp drug formularies, or vigorously pursue implementation of broad refor...read more
Citations
More filters
Journal ArticleDOI
Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries
TL;DR: These data show that the prevalence of mood and anxiety disorders and symptoms has not decreased, despite substantial increases in the provision of treatment, particularly antidepressants, in industrialized countries from 1990 to 2015.
Journal ArticleDOI
Depression in type 2 diabetes mellitus: prevalence, impact, and treatment.
Katherine Semenkovich,Miriam E. Brown,Dragan M. Svrakic,Dragan M. Svrakic,Patrick J. Lustman,Patrick J. Lustman +5 more
TL;DR: There is no escaping the paucity of the evidence base and the need for additional controlled trials that specifically address depression management in type 2 diabetes mellitus, as two recent meta-analyses of randomized controlled depression treatment trials in patients with T2DM concluded.
Journal ArticleDOI
Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.
Balazs I Bodai,Phillip Tuso +1 more
TL;DR: This article is a modest attempt to provide a comprehensive review of the long-term medical issues of breast cancer survivorship.
Journal ArticleDOI
Use of psychotropic medication in children and adolescents with autism spectrum disorders.
Daniel L. Coury,Evdokia Anagnostou,Patricia Manning-Courtney,Ann Reynolds,Lynn Cole,Robin Nemer McCoy,Agnes H. Whitaker,James M. Perrin +7 more
TL;DR: A parent report of comorbid diagnosis of attention-deficit/hyperactivity disorder, bipolar disorder, obsessive-compulsive disorder, depression, or anxiety was associated with a high rate of use, with 80% receiving ≥1 psychotropic medication.
Book
The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands?
TL;DR: The Mental Health and Substance Use Workforce for Older Adults: In Whose Hands? assesses the needs of this population and the workforce that serves it, concluding that no single approach nor isolated changes in disparate federal agencies or programs, can adequately address the issue as mentioned in this paper.
References
More filters
Journal ArticleDOI
Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care
Basit Chaudhry,Jerome K. Wang,Shinyi Wu,Margaret Maglione,Walter Mojica,Elizabeth Roth,Sally C. Morton,Paul G. Shekelle +7 more
TL;DR: This work systematically review evidence on the costs and benefits associated with use of health information technology and to identify gaps in the literature in order to provide organizations, policymakers, clinicians, and consumers an understanding of the effect ofhealth information technology on clinical care.
Journal ArticleDOI
Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.
Irving Kirsch,Brett J. Deacon,Tania B. Huedo-Medina,Alan Scoboria,Thomas J. Moore,Blair T. Johnson +5 more
TL;DR: Drug–placebo differences in antidepressant efficacy increase as a function of baseline severity, but are relatively small even for severely depressed patients.
Journal ArticleDOI
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Jay C. Fournier,Robert J. DeRubeis,Steven D. Hollon,Sona Dimidjian,Jay D. Amsterdam,Richard C. Shelton,Jan Fawcett +6 more
TL;DR: The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms.
Journal ArticleDOI
Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes.
TL;DR: Collaborative care is more effective than standard care in improving depression outcomes in the short and longer terms.
Journal Article
Collaborative care for depression : A cumulative meta-analysis and review of longer-term outcomes. Commentary
Wayne Katon,Jürgen Unützer,Simon Gilbody,Peter Bower,Janine Fletcher,David Richards,Alex J. Sutton +6 more
TL;DR: In this article, the authors conducted a systematic review of randomized controlled trials that compared collaborative care with usual primary care in patients with depression and found that collaborative care is more effective than standard care in improving depression outcomes in the short and longer terms.